Jones Financial Companies Lllp

Filing Details

13F-HR/A2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-28
Total Holdings
4,412
Total Value
111609440675
Accession Number
0000950123-25-005907
Form Type
13F-HR/A
Manager Name
Jones Financial Companies Lllp
Data Enrichment
76% identified
3,344 identified1,068 unidentified

Holdings

4,412 positions
Manager:
Search and click to pin securities to the top
Esperion Therapeutics, Inc.
Shares:
73
Value:
$110.0K
Y3894J187
Shares:
44(+10.0%)
Value:
$109.0K(-9.2%)
Vera Therapeutics, Inc.
Shares:
4
Value:
$107.0K
Repare Therapeutics Inc.
Shares:
100(+0.0%)
Value:
$105.0K(-19.8%)
Athira Pharma, Inc.
Shares:
334(+0.0%)
Value:
$102.0K(-48.0%)
RENASANT CORP
Shares:
3
Value:
$101.0K
V2X, Inc.
Shares:
2
Value:
$99.0K
Sage Therapeutics, Inc.
Shares:
12(+0.0%)
Value:
$99.0K(+52.3%)
CENTRAL GARDEN & PET CO
Shares:
3(+0.0%)
Value:
$96.0K(-3.0%)
IMMUCELL CORP /DE/
Shares:
19(+0.0%)
Value:
$95.0K(-3.1%)
PROKIDNEY CORP.
Shares:
100(+0.0%)
Value:
$91.0K(-46.1%)
RumbleOn, Inc.
Shares:
31(+0.0%)
Value:
$87.0K(-48.2%)
Aqua Metals, Inc.
Shares:
42(+0.0%)
Value:
$86.0K(-18.9%)
PALVELLA THERAPEUTICS, INC.
Shares:
3(+0.0%)
Value:
$84.0K(+133.3%)
800363103
Shares:
3
Value:
$83.0K
SEACOAST BANKING CORP OF FLORIDA
Shares:
3
Value:
$76.0K
Urban Edge Properties
Shares:
4(-20.0%)
Value:
$76.0K(-29.6%)
CureVac N.V.
Shares:
25(+0.0%)
Value:
$75.0K(-11.8%)
895970101
Shares:
122
Value:
$75.0K
Vaxart, Inc.
Shares:
173(+0.0%)
Value:
$73.0K(-36.5%)